To assess epidemiology and management practices of Latin America Pediatric Rheumatologists (LAPR) about childhood-onset systemic lupus erythematosus (cSLE). A cross-sectional study was performed in 288 LAPR PANLAR members based on online survey about cSLE practices. The response rate of web-based survey by LAPR was 170/288(59%) and the majority worked in university hospitals (63%). The ACR and/or SLICC classification criteria (99%) and disease activity tools (97%) were almost universally used by LAPR, whereas damage index (70%) and CHAQ (58%) instruments were less frequently used. Laboratory exams, diagnostic imaging, and biopsies were generally available (> 75%), however low availability for densitometry (66%). Drug access was excellent for the most common prescribed medications (> 75%), except for belimumab (11%). Emerging mosquito-borne diseases were also reported: dengue (20%), chikungunya (11%), and Zika (8%). Groups were further divided in two, according to the median number of cSLE patients followed by LAPR in the last year: groups A and B (≥ 25 and < 25, respectively). Frequencies of condom in combination with other contraceptive methods were significantly higher in group A than B (p = 0.01). The frequencies of reported pregnancy (p < 0.001) and non-adherence to therapy were significantly higher in group A (p = 0.023). Alcohol intake (p = 0.004) and illicit drug use (p = 0.007) were also reported more frequently by LAPR of group A in at least one cSLE patient. This first large web-based survey demonstrated an overall excellent access for diagnosis and therapy by LAPR, probably related to their high rate of practices in tertiary care of university hospitals. Adherence to therapy, pregnancy, and substance abuse was identified as major challenges in this population, particularly in larger centers.
Introduction
Childhood-onset systemic lupus erythematosus (cSLE) is a rare chronic inflammatory autoimmune disease that may affect many organs and systems [1] . This disease has been reported around the world, with major impact due to ethnicity in Latin America (LA) populations [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
LA includes 33 countries and dependencies, a large population, two main languages (Spanish and Portuguese), with distinct socio-economic and political status. Two groups have reported data focused on epidemiology, clinical and laboratorial features of cSLE patients in LA: BRAC-SLE (Brazilian Childhood-onset SLE Registry Group) [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and GLADEL (Grupo Latino Americano De Estudio del Lupus) [16] [17] [18] [19] .
However, to the best of our knowledge, epidemiology and management of cSLE based on LA Pediatric Rheumatologists (LAPR) were not carried out.
Therefore, the objective of the present cross-sectional survey study was to assess LAPR reports of cSLE patients regarding epidemiology, classification criteria, disease activity, and other instruments used in clinical practices, laboratory and other exams availability, general supportive care, drugs availability, infections, non-live vaccines, issues observed in adolescents, reproductive health issues, and transition-focused program to adult care. In addition, comparisons of epidemiology and management according to the number of cSLE patients followed during last year were also performed.
Methods
A cross-sectional study was conducted in 288 LAPR, based on an online survey about cSLE practices. All physicians are members of Pan-American League of Association for Rheumatology (PANLAR).
This online survey was carried out using Research Electronic Data Capture (REDCap) tool. This is a secure web instrument proposed to support data capture for research studies, offering an interface for validated data entry. This tool also audits trails for tracking data manipulation, allows automated export procedures for statistical analyses, and permits importing data from external sources.
Between June and August 2017, a questionnaire was sent to all countries that had LAPR, which included 21 countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, and Venezuela). At least five emails were sent to improve the response rate. Ethics Committee of the coordinating center, a university hospital, approved this study.
The questionnaire was composed by 20 questions of physician-reported epidemiology and management practices for cSLE patients. These questions were of multiple choiceresponse or dichotomous (yes and no), recalling observations during the last year. Estimated time for responses was nearly 15 min.
The electronic survey included 20 questions related to the following topics: Groups were further subdivided in A and B according to the median number of cSLE patients followed by LAPR in the last year: group A (≥ 25 patients in the last year) and group B (< 25 patients).
Statistical analysis
Data were presented in numbers (percentages) for categorical variables, and differences between groups A and B were assessed by Pearson chi-square of Fisher exact test, as appropriated. Data were presented in median (minimum to maximum value) or mean ± standard deviation for continuous variables according to abnormal or normal distribution, respectively, and further comparisons between groups A and B were conducted using Mann-Whitney test or Student's t test, accordingly. P values less than 0.05 were considered significant.
Results
The response rate for this web-based survey was 170/288 (59%) including 16/21 (76%) of the countries with at least one LAPR. The number of 170 surveyed specialists in each country was as follows: Brazil n = 85 (50%), Argentina n = 22 (13%), Mexico n = 22 (13%), Colombia n = 11 (6.5%), Chile n = 6 (3.6%), Venezuela n = 3 (1.8%), Paraguay n = 2 (1.1%), Ecuador n = 2 (1.1%), Nicaragua n = 2 (1.1%), Peru n = 2 (1.1%), Bolivia n = 1 (0.6%), Costa Rica n = 1 (0.6%), Dominican Republic n = 1 (0.6%), El Salvador n = 1 (0.6%), Panama n = 1 (0.6%), Uruguay n = 1 (0.6%), and absence of country reported n = 7 (4.1%). Incomplete data was observed in n = 9/170 (5.3%), and therefore 161/170 responses were evaluated.
The main clinical features of cSLE patients reported by 161 LAPR were: nephritis in 138 (86%), skin manifestations in 136 (84%), hematological involvement in 135 (84%), musculoskeletal manifestations in 116 (72%), fever in 114 (71%), serositis in 79 (49%), neuropsychiatric manifestations in 52 (32%), Raynaud phenomenon in 38 (24%), pulmonary manifestations in 22 (14%), gastrointestinal involvement in 20 (12%) and ocular involvement in 8 (5%) Table 1 shows demographic data, countries, classification criteria, disease activity and other tools used, laboratory, and other exam availability in cSLE patients followed during last year and reported by LAPR. The ACR or SLICC classification criteria (99%) and disease activity tools (97%) were almost universally used by LAPR, whereas damage index (70%) and CHAQ (58%) instruments were less frequently used. Laboratory exams, diagnostic imaging, and biopsies were generally available (> 75%), however a low availability for densitometry (66%) and anti-ribosomal P antibody (47%). The majority of LAPR had also access to other diagnostic interventions, such as renal (83%) and cutaneous biopsies (87%). With regard to general supportive care, only 66% reported sexual function orientation and the majority (> 75%) had availability for blood pressure control, physical activity recommendation, sunscreen protection, and multidisciplinary team approach. In spite of that, other supportive care access such as phone call for clinical assessment, community resources support, palliative care support, psychological support, drug compliance, dental care, rehabilitation care, family/patients counseling, adverse events monitoring, and speech language therapy consultation were reported to be available by less than 70% of the LAPR (Table 2) .
Drug access was excellent for the most commonly prescribed medications in pediatric rheumatology (> 75%), except for belimumab (11%). The majority of LAPR (92%) reported antimalarial prescription for all cSLE patients (Table  3) .
Endemic illnesses were reported by LAPR in at least one cSLE patient during the previous year: tuberculosis (16%) and Hansen disease (2%). Emerging mosquito-borne diseases were also reported in at least one patient in the same period by LAPR in Central America and in the Brazil, Colombia, Peru, and Venezuela: dengue (20%), chikungunya (11%), and Zika (8%). There were no reports of yellow fever.
The contraceptive method most often prescribed by LAPR was condom (83%), with a much lower frequency for condoms combined with other contraceptive methods (59%). A limited access to transition-focused program to adult care (61%) was observed. Ninety percent of LAPR had no strategies to prevent IVCYC infertility. Non-adherence to medication (97%) was observed in at least one adolescent cSLE patient in the previous year, and it was the main issue reported by LAPR. Cancer was reported by 10/161 (6%) LAPR. The types of cancer developed during cSLE course were non-Hodgkin lymphoma in 9/161 (5%) and ovarian cystic teratoma in 1/161 (1%) ( Table 3) .
Groups were further divided into two according to the number of cSLE patients followed by LAPR in the last year: group A (≥ 25 patients in the last year) and group B (< 25 patients). A higher frequency of full-time job (55 vs. 21%, p < 0.0001) and work in a public university hospital (65 vs. 40%, p = 0.001) was observed in group A compared to group Results are presented in n (%) cSLE childhood-onset systemic lupus erythematosus B. A significantly lower frequency of only private health insurance was observed in group A compared to group B (12 vs. 28%, p = 0.0100). LAPR of group A reported more often at least one cSLE patient during the previous year with herpes zoster (88 vs. 67%, p = 0.001), bacterial sepsis (64 vs. 36%, p < 0.001), and invasive fungal infections (21 vs. 6%, p = 0.006) than group B (Table 4) . Regarding contraception, the frequencies of condom in combination with other contraceptive methods were significantly higher in group A than group B (69 vs. 48%, p = 0.01), such as oral progesterone (59 vs. 39%, p = 0.007), depot medroxyprogesterone acetate (45 vs. 23%, p = 0.003), emergency contraception (17 vs. 4%, p = 0.007), and intrauterine device use (20 vs. 5%, p = 0.004). In spite of that, the frequency of reported pregnancy by LAPR was higher in group A (50 vs. 16%, p < 0.001). Alcohol intake (42 vs. 21%, p = 0.004) and illicit drug use (19 vs. 5%, p = 0.007) were reported more frequently by LAPR of group A in at least one cSLE patient in the previous year compared to group B (Table 4) .
The frequency of non-adherence to the therapy was similar in LAPR that reported only public health insurance compared to those that reported only private health insurance [52/55 (95%) vs. 30/32 (94%), p = 1.000].
Discussion
This is the first large web-based survey of epidemiology and management of cSLE based on LAPR practices. The great advantage of the present study was the large LAPR population of PANLAR members and the representation of the majority of LA countries. The majority had their practice in university hospitals. The high response rate, in spite of the lack of pay incentive, contrasts with the previous reports of surveys in pediatric chronic rhinosinusitis according to American Rhinologic Society (7%) [20] , in cSLE nephritis based on PR and pediatric nephrologists data (15%) [21] and perception of SLE quality indicators in North America (19%) [22] . The limitation of the present study was the convenience sample of PANLAR members and the possibility of memory bias of the respondents, since the questions were based on observation of cSLE practices during the last year.
Availability of diagnostic tests and therapy was beyond the expectation. The overall evaluation revealed that almost all parameters included in the quality of medical care in cSLE patients were available for LAPR [23] . We believe that the availability reported may not indicate easy access since in our experience in Brazil, the prescription of high cost drugs is usually followed by a long and time-consuming bureaucratic process with several restrictions that may limit its use.
We confirmed and extended previous observation that renal biopsy access is lower in Latin America than USA and further demonstrated that for LA, the rate is higher than previously reported in two centers in Brazil [23] . This procedure was provided more often by large centers. Bone densitometry access was lower than others diagnostic imaging, but within the range reported in three other USA centers [23] . With regard to supportive care related to the multidisciplinary team care, the availability was high for general supportive care. Conversely, we identified limited access for specialized multidisciplinary approach required for satisfactory care, such as psychological support, dental care, palliative care support, and speech and language therapy. Indeed, the relevance of the availability of these resources for better management of cSLE was previously emphasized [24, 25] .
The most relevant issue observed by LAPR was the nonadherence of medication, in spite of high frequencies of glucorticosteroid, antimalarials, and immunosuppressive availability. Compliance is a determinant factor on cSLE outcome [26] [27] [28] , and Brazilian Society of Rheumatology Consensus for SLE reinforced the importance to evaluate adherence in all appointments, especially for adolescents [29] . Furthermore, alcohol intake and illicit drug were also important issues evidenced in adolescents, particularly reported by LAPR in large centers. These results may be due to the easier access of these substances in LA [30] , despite the public health policies in many of the countries.
The majority of the cSLE patients followed by LAPR in large centers seemed to be from a low socioeconomic and low educated cohort of lupus, since over three-quarters of the patients were from the public university setting. In addition, approximately 10% of LAPR had access only to private health insurance.
Severe infections were a relevant issue, such as herpes zoster, bacterial sepsis, and invasive fungal infections, and they were more often observed in large centers. In fact, infections are an important cause of morbidity and mortality in cSLE populations associated with systemic, active disease and under immunosuppressive therapy [2-4, 31, 32] . Of note, in LA, emerging infectious diseases (chikungunya, dengue, Ovarian cystic teratoma 1 (1) Pregnancy 54 (33) Results are presented in n (%) cSLE childhood-onset systemic lupus erythematosus, IVCYC Intravenous cyclophosphamide, GNRHa gonadotropin-releasing hormone agonist and Zika) are relevant differential diagnosis for mosquitoborne viral infections, particularly in endemic areas [33] , as demonstrated herein by the report of at least 20% of the LAPR.
Regarding reproductive health, condom was the most often prescribed contraceptive method despite the high rate of nonadherence reported by LAPR. The recommendation of supervised injection or implant progesterone contraceptive in day hospital [34, 35] combined with condom should be reinforced to avoid the high rate of pregnancies reported by LAPR.
Female and male strategies to prevent infertility in cSLE patients under IVCYC use were rarely reported by LAPR, probably due to the high financial cost of these medications [36] [37] [38] . Well-established transition programs are still a challenge in LA clinical practice. A recent survey to assess transition practices in Brazil showed that only 14% of the pediatric rheumatologists were satisfied with their current transition process [39] .
The most important clinical features reported by LAPR were nephritis, skin, hematological, musculoskeletal, fever, serositis, and neuropsychiatric. Renal involvement, hematological, seizure, and ocular manifestations, vasculitis, and fever were significantly higher in cSLE compared to adult SLE patients [40] .
In conclusion, this survey demonstrated overall excellent access to diagnosis and therapy for cSLE, probably related to their high rate of specialists practice in university hospitals. Adherence to therapy, pregnancy, and substance abuse was identified as major challenges in this population particularly in larger centers.
